Assignee
ARVINAS INC
US8 patents
Top patents by PatentIndex Score
US10647698B2May 12, 2020
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
ARVINAS INC31 citations98
US10584101B2Mar 10, 2020
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS INC35 citations97
US10772962B2Sep 15, 2020
Compounds and methods for the targeted degradation of bromodomain-containing proteins
ARVINAS INC15 citations94
US10730870B2Aug 4, 2020
Compounds and methods for the enhanced degradation of targeted proteins
ARVINAS INC25 citations93
US10723717B2Jul 28, 2020
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
ARVINAS INC16 citations85
US11352351B2Jun 7, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS INC4 citations73
US10604506B2Mar 31, 2020
Modulators of estrogen receptor proteolysis and associated methods of use
ARVINAS INC3 citations73
US11458123B2Oct 4, 2022
Tau-protein targeting PROTACs and associated methods of use
ARVINAS INC2 citations71